ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

BMRA Biomerica Inc

0,5529
-0,0371 (-6,29%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Biomerica Inc BMRA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,0371 -6,29% 0,5529 01:56:39
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,5717 0,5326 0,5949 0,5316 0,59
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/5/202414:19GLOBEBiomerica Announces inFoods® IBS Pilot Launch with Prominent..
10/5/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/5/202423:15EDGAR2Form 8-K - Current report
29/4/202414:19GLOBEBiomerica and Leading UAE Healthcare Company Forge a Path to..
15/4/202413:47GLOBEBiomerica provides update on inFoods® IBS expansion
13/4/202401:23GLOBEBiomerica Reports Third Quarter 2024 Financial Results
28/3/202413:19GLOBEBiomerica InFoods IBS Data to be Presented at the Upcoming..
21/2/202414:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
14/2/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202421:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
23/1/202414:19GLOBEDiagnostics Industry Leader Jack Kenny Appointed as Chairman..
16/1/202414:19GLOBEBiomerica Reports Second Quarter 2024 Financial Results
16/1/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/12/202313:47GLOBEBiomerica Received US FDA 510(k) Clearance for Their Hp..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:19EDGAR2Form 8-K - Current report
11/12/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202314:19GLOBEBiomerica to Participate in 14th Annual Craig-Hallum Alpha..
08/11/202314:19GLOBEBiomerica Expands inFoods IBS Reach with Addition of Several..
13/10/202319:10GLOBEREPEAT - Biomerica Reports First Quarter 2024 Financial..
13/10/202312:39GLOBEBiomerica Reports First Quarter 2024 Financial Results
12/10/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/10/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
27/9/202323:15EDGAR2Form DEF 14A - Other definitive proxy statements
26/9/202314:19GLOBEDubai Government Grants Insurance Reimbursement for..
22/9/202321:05GLOBEMaxim Group LLC to Host the Virtual Tech Conference Series:..
19/9/202319:20EDGAR2Form 8-K - Current report
28/8/202314:19GLOBEDiagnostics Industry Leader Jack Kenny Joins Biomerica’s..
28/8/202314:10EDGAR2Form 8-K - Current report
25/8/202323:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
25/8/202323:00GLOBEBiomerica Reports Fiscal 2023 Year End Results
03/8/202314:19GLOBECVS Health to Begin Nationwide In-Store Sales of Biomerica’s..
26/7/202322:46EDGAR2Form 8-K - Current report
21/6/202314:19GLOBEBiomerica Receives Notice of Patent Allowance in China for a..